Complaint Investigation Report

The five staff were also able to explain the infection control procedures. A facility staff also indicated that a skin test was requested to R1's hospice agency due to R1 being under their care and R1 presenting an unknown rash. One facility staff and witness interview stated that hospice offers palliative care that is solely symptom focused. Per the hospice charting, R1 was prescribed Ivermectin and Permethrin, to treat the scabies which improved the symptoms and cleared the rash. As of today's date, the diagnosis for the rash is unknown and facility did not pursue a test for R1. One out of the three residents interviewed confirmed having a rash while the remaining residents denied having or witnessing rash on other residents or staff. Three out of the three residents confirmed that the facility cleans and offers laundry services daily.

Therefore, due to conflicting information, LPA is unable to corroborate the allegation. Based on the observations made, interviews which were conducted, and the records that were reviewed, although the allegation may have happened or are valid, there is not a preponderance of evidence to prove the alleged violation did or did not occur, therefore the following allegation: Facility did not implement precautions for scabies outbreak is deemed UNSUBSTANTIATED.

An exit interview was conducted with Administrator Aurelia Olais and Resident Care Director Paula Tangloa, and a copy of this report was provided at the end of the visit.